1. 1206 Do participants in the phase I trials need to be hospitalized? Domestic but outstanding issues for globalization in Japan. (September 2015) Authors: Shimomura, A.; Kondo, S.; Tanabe, Y.; Kitano, S.; Iwasa, S.; Fujiwara, Y.; Tamura, K.; Yamamoto, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 124P Phase II study of neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage IIIA-B N2 non-small cell lung cancer: SQUAT trial (WJOG 12119L). (December 2022) Authors: Miyoshi, T.; Hamada, A.; Soh, J.; Hata, A.; Nakamatsu, K.; Shimokawa, M.; Yatabe, Y.; Suzuki, J.; Tsuboi, M.; Horinouchi, H.; Yoshino, I.; Masayuki, T.; Toyooka, S.; Okada, M.; Go, T.; Yamashita, M.; Nishimura, Y.; Yamamoto, N.; Nakagawa, K.; Mitsudomi, T. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1362PSafety and clinical activity of DS-6051b, a ROS1/NTRK inhibitor, in Japanese patients with NSCLC harboring ROS1 fusion gene. (18th September 2017) Authors: Takeda, M.; Seto, T.; Fujiwara, Y.; Yamamoto, N.; Nosaki, K.; Toyozawa, R.; Abe, C.; Shiga, R.; Nakamaru, K.; Nakagawa, K. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1955 Primary systemic therapy by dual HER2 blockage with lapatinib (La) + trastuzumab (T) for Japanese patients (pts) with HER2+ breast cancer (BC): Association of La toxicity and dose with treatment efficacy. (September 2015) Authors: Yamashita, T.; Masuda, N.; Yamamoto, N.; Kondo, N.; Bando, H.; Akiyoshi, S.; Ohtani, S.; Takano, T.; Inoue, K.; Fujisawa, T.; Ishiguro, H.; Nakayama, H.; Aogi, K.; Amano, S.; Ozaki, H.; Yasojima, H.; Kasai, H.; Kataoka, T.R.; Morita, S.; Toi, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 230 Feasibility study of targeted sequencing-based molecular prescreening of patients for Phase I clinical trials. Trial of Oncopanel for Introduction into Clinical Study Phase 1 (TOPICS-1). (September 2015) Authors: Tanabe, Y.; Ichikawa, H.; Kohno, T.; Yoshida, H.; Kubo, T.; Iwasa, S.; Ochiai, A.; Yamamoto, N.; Tamura, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 314 Phase 1 study of abemaciclib, a CDK 4 and 6 inhibitor, as a single agent for Japanese patients with advanced cancer. (September 2015) Authors: Kondo, S.; Yamamoto, N.; Tamura, K.; Tanabe, Y.; Iwasa, S.; Shimomura, A.; Shibasaki, Y.; Ogasawara, K.; Turner-Jones, K.; Mori, J.; Asou, H.; Michael Chan, E.; Fujiwara, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 352 Phase Ia/Ib study of pan-PI3K inhibitor, pictilisib (GDC-0941), in Japanese patients with advanced solid tumors or non-squamous non-small cell lung cancer (JO28645 study). (September 2015) Authors: Yanagitani, N.; Horiike, A.; Kitazono, S.; Tamura, K.; Kondo, S.; Iwasa, S.; Tanabe, Y.; Inatani, M.; Nakamura, K.; Kotani, N.; Yamamoto, N.; Nishio, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 36th International Symposium on Intensive Care and Emergency Medicine. Issue 2 (April 2016) Authors: Bateman, R.; Sharpe, M.; Jagger, J.; Ellis, C.; Solé-Violán, J.; López-RodrÃguez, M.; Herrera-Ramos, E.; RuÃz-Hernández, J.; BorderÃas, L.; Horcajada, J.; González-Quevedo, N.; Rajas, O.; Briones, M.; RodrÃguez de Castro, F.; RodrÃguez Gallego, C.; Esen, F.; Orhun, G.; Ergin Ozcan, P.; ... Journal: Critical care Issue: Volume 20:Issue 2(2016) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 41. A multi-center prospective study of radiofrequency ablation without surgical excision for small breast carcinomas. Issue 9 (September 2016) Authors: Kinoshita, T.; Doihara, H.; Yamamoto, N.; Fujisawa, T.; Takahashi, M.; Aogi, K.; Tsuda, H.; Yoshida, M.; Hojo, T.; Jimbo, K.; Asaga, S.; Takayama, S. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 512 A phase 1 study to assess the safety and tolerability of tremelimumab alone and in combination with MEDI4736 in Japanese patients with advanced solid malignancies. (September 2015) Authors: Takahashi, Y.; Fujikawa, K.; Sagawa, T.; Fujiwara, Y.; Iwasa, S.; Yamamoto, N.; Sugeno, M.; Tsuno, H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗